Loading content…
Affiliate-supportedIndependent editorialWe never sell medicationSee how
Midwest · Minnesota
Local context for Wegovy, Ozempic, Mounjaro, and Zepbound in Minneapolis (430,000 residents, 3,700,000 metro). Twin Cities metro is anchored by U of M / M Health Fairview and Allina/Abbott Northwestern; Mayo Clinic in nearby Rochester is a regional draw.
Availability and prices vary by pharmacy and date. We do not maintain real-time per-pharmacy stock data. Confirm with pharmacies directly.
Wegovy
semaglutide · Novo Nordisk
Once-weekly semaglutide injection FDA-approved for chronic weight management in adults and adolescents.
Wegovy in Minneapolis →
Ozempic
semaglutide · Novo Nordisk
Once-weekly semaglutide injection FDA-approved for adults with type 2 diabetes.
Ozempic in Minneapolis →
Mounjaro
tirzepatide · Eli Lilly
Once-weekly tirzepatide injection FDA-approved for adults with type 2 diabetes.
Mounjaro in Minneapolis →
Zepbound
tirzepatide · Eli Lilly
Once-weekly tirzepatide injection FDA-approved for chronic weight management and obstructive sleep apnea.
Zepbound in Minneapolis →
Minneapolis is a midwest-region city with a population of 430,000 (3,700,000 in the broader metropolitan area). Minnesota expanded Medicaid under the Affordable Care Act, which means low-income adults can typically qualify for GLP-1 coverage for type 2 diabetes if the state Medicaid program lists the drug.
Statewide, notable health systems include Mayo Clinic, M Health Fairview.
Minnesota's Medicaid program is Minnesota Medical Assistance. Coverage rules for GLP-1 medications vary by drug and indication; see our pricing by state map and payer-coverage guides for details.
Cities of similar size with comparable healthcare markets.